This HTML5 document contains 168 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q39242384
rdf:type
wikibase:Item
schema:description
2016年論文 articolo scientifico vedecký článok videnskabelig artikel мақолаи илмӣ 2016年论文 επιστημονικό άρθρο 2016年論文 article científic scientific article published on 24 October 2016 наукова стаття, опублікована в жовтні 2016 artigo científico 2016年论文 bài báo khoa học 2016年論文 artykuł naukowy مقالة علمية نشرت في 24 أكتوبر 2016 scientific article published on 24 October 2016 scienca artikolo სამეცნიერო სტატია artigo científico artículo científico publicado en 2016 artikel ilmiah ২৪ অক্টোবর ২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ naučni članak wissenschaftlicher Artikel บทความทางวิทยาศาสตร์ 2016年论文 artikulong pang-agham научная статья 2016年論文 vetenskaplig artikel wetenschappelijk artikel bilimsel makale 2016년 논문 teaduslik artikkel 2016年论文 article scientifique artículu científicu espublizáu en 2016 2016年の論文 vitenskapelig artikkel article scientific научни чланак 2016年論文 tieteellinen artikkeli scientific article published on 24 October 2016 tudományos cikk artigo científico 2016年论文 научни чланак vitskapeleg artikkel מאמר מדעי articol științific vědecký článek artikull shkencor 2016 nî lūn-bûn научна статия 2016年论文
p:P577
wds:Q39242384-6DE71FDC-D45D-4212-9397-1E66AD1F8B39
wdt:P577
2016-10-24T00:00:00Z
p:P407
wds:Q39242384-C74FAAC4-41C1-48EC-9AC1-A5DCF622A0D5
wdt:P407
wd:Q1860
p:P2860
wds:Q39242384-0EC993EC-E61C-498E-9A67-085EA3204BFF wds:Q39242384-134E690C-AC3D-49E2-8851-5D16B6F21647 wds:Q39242384-13606D6A-DF8B-428E-9131-A1F59BD7BB9E wds:Q39242384-17FAAF18-52A5-40BC-A6E9-7BD497BB3328 wds:Q39242384-0CEFD5B5-98C7-4584-902E-C40D90EB327F wds:Q39242384-0E8AB95D-5EFD-467A-8322-667EEC7C461B wds:Q39242384-8E797A7B-DB3A-4B31-ACD2-37B02A7606D2 wds:Q39242384-916039F5-AD9C-4F26-BC98-DDF243A108C9 wds:Q39242384-94C8B856-9E25-4CF5-910B-6D01FF02675B wds:Q39242384-7FDFDB03-05A8-4BB3-A1AF-168F3F040FD7 wds:Q39242384-82F0EBF8-F6C9-4F67-B13D-C6785F121AFC wds:Q39242384-85841D24-CA01-4310-8D2E-90A785C064F9 wds:Q39242384-A979DC53-3F68-4459-A3C0-043B82E5BCFE wds:Q39242384-37197BDA-2340-4950-BA60-D84BEC2EE329 wds:Q39242384-40A0A80C-58EE-46F3-B12B-D081902D6537 wds:Q39242384-2409149D-0799-4CF5-B98C-0EBFAE5CB9F3 wds:Q39242384-29371D9A-2413-4A29-AFF0-CAD2D6EB093F wds:Q39242384-5D3FDD30-8EC1-4934-9CAA-5B80C7330FCD wds:Q39242384-46CE87B1-BBD8-4DF6-A1D9-4C854C9307C5 wds:Q39242384-53452476-1487-43AB-A818-64B7B0F3FB80 wds:Q39242384-544CCE98-9F5D-42B1-B856-2D6CC5E08201 wds:Q39242384-D45FBBCC-7608-4246-B556-B6DA197A4CB3 wds:Q39242384-C7B3FE9B-0D29-4808-A9B4-6EE300DFDFC1 wds:Q39242384-CF6D529E-FEF8-4C2B-9A98-8966C8B0A363 wds:Q39242384-D0667E6B-5EB1-4D70-90D1-957764064176 wds:Q39242384-EF75944D-7FA9-4083-BA98-B1B29F048190
wdt:P2860
wd:Q87494269 wd:Q33180279 wd:Q35678721 wd:Q33237384 wd:Q39069499 wd:Q30413346 wd:Q43609062 wd:Q35793026 wd:Q57903637 wd:Q85636564 wd:Q37966566 wd:Q37893421 wd:Q27860576 wd:Q67975852 wd:Q33683007 wd:Q35517957 wd:Q56019470 wd:Q88194312 wd:Q34713298 wd:Q37777635 wd:Q37122293 wd:Q63199185 wd:Q63199204 wd:Q38215703 wd:Q51157019 wd:Q63199181
rdfs:label
Patterns of recurrence and outcomes in surgically treated women with endometrial cancer according to ESMO-ESGO-ESTRO Consensus Conference risk groups: Results from the FRANCOGYN study Group Patterns of recurrence and outcomes in surgically treated women with endometrial cancer according to ESMO-ESGO-ESTRO Consensus Conference risk groups: Results from the FRANCOGYN study Group Patterns of recurrence and outcomes in surgically treated women with endometrial cancer according to ESMO-ESGO-ESTRO Consensus Conference risk groups: Results from the FRANCOGYN study Group
skos:prefLabel
Patterns of recurrence and outcomes in surgically treated women with endometrial cancer according to ESMO-ESGO-ESTRO Consensus Conference risk groups: Results from the FRANCOGYN study Group Patterns of recurrence and outcomes in surgically treated women with endometrial cancer according to ESMO-ESGO-ESTRO Consensus Conference risk groups: Results from the FRANCOGYN study Group Patterns of recurrence and outcomes in surgically treated women with endometrial cancer according to ESMO-ESGO-ESTRO Consensus Conference risk groups: Results from the FRANCOGYN study Group
schema:name
Patterns of recurrence and outcomes in surgically treated women with endometrial cancer according to ESMO-ESGO-ESTRO Consensus Conference risk groups: Results from the FRANCOGYN study Group Patterns of recurrence and outcomes in surgically treated women with endometrial cancer according to ESMO-ESGO-ESTRO Consensus Conference risk groups: Results from the FRANCOGYN study Group Patterns of recurrence and outcomes in surgically treated women with endometrial cancer according to ESMO-ESGO-ESTRO Consensus Conference risk groups: Results from the FRANCOGYN study Group
p:P50
wds:Q39242384-693D569A-899C-441E-8A1C-62F9D6DA16FA wds:Q39242384-25B1F2F1-96D9-45AA-BBFD-B4E87D22C51D wds:Q39242384-36C3B9DF-9CD8-4308-8FE9-A42C63E68A66 wds:Q39242384-9A7CF0F0-FAE5-4754-83D3-2EF7F1AC1390 wds:Q39242384-9C71294B-7E65-45BD-86CC-8FCC11861F19 wds:Q39242384-C4F483A2-6DD1-4EBF-854C-23DC4376B586 wds:Q39242384-C742A2E1-D0ED-42DB-8BED-F8F65BAFBC1A wds:Q39242384-857ECADA-D6B5-4DE9-A09A-D2423F004637 wds:Q39242384-8A32216C-C17E-402E-BE1D-87CE51E9366F wds:Q39242384-E4E76682-B030-47DD-B09E-9F7E6A7D64E4 wds:Q39242384-02967BFD-D644-43CE-97DC-DA06B0D901FC wds:Q39242384-0CC640E2-40B9-4C22-BBAA-6B779C0996C8
wdt:P50
wd:Q57423534 wd:Q33106557 wd:Q115215903 wd:Q116781783 wd:Q88004136 wd:Q90156052 wd:Q89695024 wd:Q91909264 wd:Q91909279 wd:Q91909260 wd:Q116781792 wd:Q91909269
p:P1476
wds:Q39242384-C8A4E5B2-3921-4F68-84CF-5D590DD21AEA
wdt:P1476
Patterns of recurrence and outcomes in surgically treated women with endometrial cancer according to ESMO-ESGO-ESTRO Consensus Conference risk groups: Results from the FRANCOGYN study Group
p:P304
wds:Q39242384-9AC0D488-773D-410E-856F-3A8439835F28
wdt:P304
107-112
p:P31
wds:Q39242384-543D370A-4A02-4781-8E3C-323B6CAA924C
wdt:P31
wd:Q13442814
p:P921
wds:Q39242384-6857CE03-787E-476E-94F1-8AAFA3A3E33A
wdt:P921
wd:Q944777
p:P698
wds:Q39242384-3614B456-6599-49E5-88C6-02153083F425
wdtn:P698
n9:27789083
wdt:P698
27789083
p:P1433
wds:Q39242384-DEA37EF5-4B41-4304-80FD-BB87483E52B7
wdt:P1433
wd:Q5625182
p:P433
wds:Q39242384-1F996C98-0364-486C-B992-53B883274044
p:P478
wds:Q39242384-C2DEB05C-3975-444D-B013-2338585C669A
wdt:P433
1
wdt:P478
144
p:P356
wds:Q39242384-D95D4CB6-6712-4019-B2F6-69546F73D6C3
wdtn:P356
n12:J.YGYNO.2016.10.025
wdt:P356
10.1016/J.YGYNO.2016.10.025